Emerging Technologies

The study indicated that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection. 

VR researcher and advocate Dr. Robert Louis gives HIMSS Media insight on the current state of VR in healthcare, and how the virus has impacted his hospital's rollout of the technology.  

Flare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies tackling the ongoing opioid epidemic.

The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed.

Panelists at BIO Digital discuss the obstacles of implementing digital tools to treat asthma and COPD patients, as well as the opportunity. 

The recently unveiled, liquid-free UVLicht Sterilizer is the first brand of its kind to be founded in the Emirates. Currently self-funded by its founder, the company is reportedly in the process of scoping investors. 

The past weeks have seen a wave of health tech companies pledging support to anti-racism protesters, as well as public pressure for clear action steps.

Also - NHS Digital integrates the eConsult digital triaging service into the NHS App. 

HP's Daniel Colling and Raja Bhadury explain the company's moves to enhance telemedicine, accelerate vaccination research, and improve data and device security in the battle against the pandemic.

Dr. Amy Compton-Phillips, EVP and chief clinical officer at Providence St. Joseph Health, discusses how the coronavirus pandemic will affect the future of clinical care.